Medtronic (MDT) Capital Expenditures (2014 - 2026)

Medtronic has disclosed Capital Expenditures across 13 years of filings, most recently posting $503.0 million for Q3 2026.

• In Q3 2026, Capital Expenditures changed 0.2% year-over-year to $503.0 million; the TTM figure through Jul 2026 stood at $1.9 billion (up 3.26% YoY), while the FY2026 annual figure was $1.9 billion, up 2.42% from the prior year.
• Capital Expenditures came in at $503.0 million for Q3 2026 at Medtronic, up from $488.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $520.0 million in Q3 2024 to a low of $323.0 million in Q4 2022.
• Average Capital Expenditures over 5 years is $422.7 million, with a median of $426.0 million recorded in 2022.
• Year-over-year, Capital Expenditures declined 16.9% in 2023 and soared 46.89% in 2024.
• Over 5 years, Capital Expenditures stood at $323.0 million in 2022, then jumped by 42.72% to $461.0 million in 2023, then declined by 12.36% to $404.0 million in 2024, then gained by 15.84% to $468.0 million in 2025, then rose by 7.48% to $503.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $503.0 million in Q3 2026, $488.0 million in Q2 2026, and $444.0 million in Q1 2026.